Neurology Minute
American Academy of Neurology
The Neurology Minute podcast delivers a brief daily summary of what you need to know in the field of neurology, the latest science focused on the brain, and timely topics explored by leading neurologists and neuroscientists. From the American Academy of Neurology and hosted by Stacey Clardy, MD, Ph.D., FAAN, with contributions by experts from the Neurology journals, Neurology Today, Continuum, and more.
Episodes
Mentioned books
Sep 30, 2024 • 6min
The Topic of Neurological Care for Transgender Patients - Part 3
In the final part of this three-part series, Dr. Halley Alexander and Dr. Gwen Zeigler discuss the management of epilepsy in transgender or gender diverse patients. Show reference: https://www.neurology.org/doi/abs/10.1212/CPJ.0000000000200332
Sep 27, 2024 • 4min
Relapsing-Remitting Immunotherapy Responsive SFN
Dr. Shuvro Roy, a clinician specializing in small-fiber neuropathy, teams up with Dr. Anne Louise Oaklander, a leading expert in the field. They delve into the challenges of diagnosing this often-misunderstood condition, emphasizing the importance of recognizing sensory and autonomic symptoms. The discussion also highlights the exciting potential of immunotherapy for treating autoimmune-related neuropathy, offering fresh insights for clinicians and patients alike.
Sep 26, 2024 • 2min
Gender Discrepancies in Leadership Roles and Recognition Awards in the Child Neurology Society
Dr. Dara Albert and Dr. Jaclyn M. Martindale discuss the differences in gender representation among leadership positions and award recipients within the Child Neurology Society. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209746
Sep 25, 2024 • 4min
The Topic of Neurological Care for Transgender Patients - Part 2
In part two of this three-part series, Dr. Halley Alexander and Dr. Gwen Zeigler discuss cerebrovascular risk and management in transgender and gender-diverse patients. Show reference: https://www.neurology.org/doi/abs/10.1212/CPJ.0000000000200332
Sep 24, 2024 • 4min
The Topic of Neurological Care for Transgender Patients - Part 1
In part one of this three-part series, Dr. Halley Alexander and Dr. Gwen Zeigler discuss the crucial aspects about managing headaches in transgender and gender-diverse patients. Show reference: https://www.neurology.org/doi/abs/10.1212/CPJ.0000000000200332
Sep 23, 2024 • 2min
A General Neurologist's Practical Diagnostic Algorithm for Atypical Parkinsonian Disorders - Part 2
In part two of this two-part series, Drs. Jeff Ratliff, Michiko K. Bruno, and Lawrence Golbe discuss essential advice for general neurologists who suspect a patient might have an atypical disorder. Show reference: https://www.neurology.org/doi/full/10.1212/CPJ.0000000000200345
Sep 19, 2024 • 2min
CMAP and Myosin-Loss Pathology in Patients With Critical Illness Myopathy
Drs. Gordon Smith, Shahar Shelly, and Teerin Liewluck discuss the correlation between CMAP duration and myosin loss and their effect on mortality by comparing between patients with CIM with and without myosin loss. Show references: https://www.neurology.org/doi/10.1212/WNL.0000000000209496
Sep 18, 2024 • 2min
Improving Clinical Documentation Efficiency with AI
Dr. Irfan Sheikh, an expert in neurology and AI, dives into the transformative role of artificial intelligence in clinical documentation. He discusses ambient intelligence and how it can streamline processes in neurology, enhancing efficiency and accuracy. Sheikh also touches on the importance of maintaining human oversight, especially while addressing the challenges of managing disorders like Rett Syndrome. The conversation underscores the need for improved treatment strategies while embracing innovative technology in healthcare.
Sep 17, 2024 • 4min
Monoclonal Antibody to PACAP for Migraine Prevention - Part 2
Dr. Tesha Monteith, a dedicated migraine researcher, joins Dr. Messoud Ashina, an expert in migraine treatment, to delve into a groundbreaking phase two study on a monoclonal antibody targeting PACAP for migraine prevention. They highlight its efficacy and safety compared to placebo, address the pressing need for new treatments, and share insights on reported adverse effects. The discussion also hints at exciting future research directions that could transform migraine management. This is vital listening for anyone interested in migraine solutions!
Sep 16, 2024 • 3min
Depression During Intern Year Increases Risk for Persistent MD Depression: What Can Training Programs Do to Intervene
Dr. Rae Bacharach discusses the Neurology Today article, "Depression During Intern Year Increases Risk for Persistent MD Depression: What Can Training Programs Do to Intervene?" by Gina Shaw, available in the September 5th issue of Neurology Today or at neurologytoday.com. Show reference: https://journals.lww.com/neurotodayonline/fulltext/2024/09050/large_study_finds_covid_vaccination_does_not.3.aspx
